LeafNLP Demos
Back to explore

Report #2890873

Received Mar 26, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
NJ
Recovered
Unknown
Vaccinated
Mar 10, 2026
Onset
Mar 10, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MNQMENINGOCOCCAL CONJUGATE (MENVEO)NOVARTIS VACCINES AND DIAGNOSTICS27742A—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

Less than recommended interval; This non-serious case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a patient who received Men ACWY-CRM NVS (Menveo) (batch number 7742A, expiry date 31-JAN-2027) for prophylaxis. Previously administered products included Menveo (received 1st dose on 27-FEB-2025). On 10-MAR-2026, the patient received the 2nd dose of Menveo. On 10-MAR-2026, an unknown time after receiving Menveo, the patient experienced drug dose administration interval too short (Verbatim: Less than recommended interval). The outcome of the drug dose administration interval too short was not applicable. Additional Information: GSK Receipt Date: 11-MAR-2026 The vaccine administration facility was the same as primary reporter.